ArticleMolecular oncology2021

Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non-small-cell lung cancer treated with pembrolizumab.

Patricia Mondelo-Macía et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.